BROADWOOD CAPITAL INC Long-Term Concentrated

Location: New York, NY

CIK: 0001278387 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value: $544M (100.0% shares, 0.0% debt)

Holdings (8)

MNST MONSTER BEVERAGE CORP NEW 43.8%

Value $238M Shares 4,797,408 Est. Cost $22.71 Unrealized +6.1%

STAA STAAR SURGICAL CO 21.6%

Value $117M Shares 10,855,179 Est. Cost $8.21 Unrealized +19.1%

— BIOTIME INC 15.7%

Value $85.43M Shares 27,119,254 Est. Cost $3.49 Unrealized —

IWM ISHARES TR 10.9%

Value $59.19M Shares 420,000 Est. Cost $109.78 Unrealized —

— ONCOCYTE CORPORATION 2.9%

Value $15.89M Shares 3,056,680 Est. Cost $5.60 Unrealized —

— MALLINCKRODT PUB LTD CO 2.7%

Value $14.45M Shares 322,411 Est. Cost $90.15 Unrealized —

— ASTERIAS BIOTHERAPEUTICS INC 2.4%

Value $13.13M Shares 3,699,848 Est. Cost $3.75 Unrealized —

— ASTERIAS BIOTHERAPEUTICS INC 0.0%

Value $164K Shares 328,205 Est. Cost $0.21 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MNST	MONSTER BEVERAGE CORP NEW	4,797,408	$238M	43.8%	$22.71	+6.1%	COM	61174X109
STAA	STAAR SURGICAL CO	10,855,179	$117M	21.6%	$8.21	+19.1%	COM PAR $0.01	852312305
—	BIOTIME INC	27,119,254	$85.43M	15.7%	$3.49	—	COM	09066L105
IWM	ISHARES TR	420,000	$59.19M	10.9%	$109.78	—	RUSSELL 2000 ETF	464287655
—	ONCOCYTE CORPORATION	3,056,680	$15.89M	2.9%	$5.60	—	COM	68235C107
—	MALLINCKRODT PUB LTD CO	322,411	$14.45M	2.7%	$90.15	—	SHS	G5785G107
—	ASTERIAS BIOTHERAPEUTICS INC	3,699,848	$13.13M	2.4%	$3.75	—	COM SER A	04624N107
—	ASTERIAS BIOTHERAPEUTICS INC	328,205	$164K	0.0%	$0.21	—	*W EXP 09/29/201	04624N115